Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China flag China · Delayed Price · Currency is CNY
9.56
-0.03 (-0.31%)
Apr 28, 2026, 3:00 PM CST

SHA:600420 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,0066,2125,9736,1484,284
Short-Term Investments
3,0551,431---
Cash & Short-Term Investments
7,0617,6435,9736,1484,284
Cash Growth
-7.61%27.97%-2.86%43.51%15.18%
Accounts Receivable
1,1671,3612,0512,6563,048
Other Receivables
81.5585.5584.0792.8596.91
Receivables
1,2481,4472,1352,7483,144
Inventory
1,7492,2092,2802,4403,072
Prepaid Expenses
71.0770.2961.6347.6940.21
Other Current Assets
1,123315.43207.49300.4345.15
Total Current Assets
11,25311,68410,65711,68410,886
Property, Plant & Equipment
5,3415,5505,8856,2466,511
Long-Term Investments
1,2331,3161,431376.22370.77
Goodwill
160.15160.15160.15160.15160.15
Other Intangible Assets
759.99591.29511.18517.08549.09
Long-Term Deferred Tax Assets
115.82103.15153.13239.09188.75
Long-Term Deferred Charges
227.36333.66331.74227.83144.74
Other Long-Term Assets
136.21216.67223.65179.17259.22
Total Assets
19,22719,95619,35219,63019,070
Accounts Payable
1,6481,1031,3741,2491,542
Accrued Expenses
935.671,4201,5951,6751,670
Short-Term Debt
-50.0545.05321.142,014
Current Portion of Long-Term Debt
-1,031-48.37539.63
Current Portion of Leases
8.858.8610.69.8640.13
Current Income Taxes Payable
44.2572.5129.9537.9430.86
Current Unearned Revenue
93.81193.33244.6344.17201.23
Other Current Liabilities
403.65465.17480.59509.97804.25
Total Current Liabilities
3,1344,3443,7804,1966,843
Long-Term Debt
--1,0312,9551,547
Long-Term Leases
33.7547.9457.9768.5743
Long-Term Unearned Revenue
83.49113.99122.8138.01140.33
Pension & Post-Retirement Benefits
11.410.360.520.570.84
Long-Term Deferred Tax Liabilities
62.570.7722.15119.55126.19
Other Long-Term Liabilities
56.9656.96---
Total Liabilities
3,3824,6345,0147,4788,700
Common Stock
1,3411,3411,3411,1721,027
Additional Paid-In Capital
5,2135,2045,2043,5872,545
Retained Earnings
7,2266,6605,8455,2874,762
Comprehensive Income & Other
-1.11-0.91-1.09259.34258.88
Total Common Equity
13,77913,20412,38810,3058,593
Minority Interest
2,0662,1181,9501,8471,777
Shareholders' Equity
15,84515,32214,33812,15310,370
Total Liabilities & Equity
19,22719,95619,35219,63019,070
Total Debt
42.61,1381,1453,4034,184
Net Cash (Debt)
7,0186,5054,8282,74599.84
Net Cash Growth
7.89%34.74%75.89%2649.36%-
Net Cash Per Share
5.234.853.792.370.08
Filing Date Shares Outstanding
1,3411,3411,3411,1721,027
Total Common Shares Outstanding
1,3411,3411,3411,1721,027
Working Capital
8,1197,3406,8777,4894,044
Book Value Per Share
10.279.859.248.578.11
Tangible Book Value
12,85912,45211,7179,6287,884
Tangible Book Value Per Share
9.599.288.747.997.42
Buildings
4,3854,4914,4723,9453,874
Machinery
8,5258,4538,3708,1847,920
Construction In Progress
208.91142.68101.35642.37585.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.